104 related articles for article (PubMed ID: 11360919)
1. Quinolones alter defense reactions mediated by macrophages.
Azuma Y; Shinohara M; Wang PL; Ohura K
Int Immunopharmacol; 2001 Feb; 1(2):179-87. PubMed ID: 11360919
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of modulatory effect to the function of rat peritoneal neutrophils treated with new quinolones.
Azuma Y; Wang PL; Shinohara M; Okamura M; Inui Y; Suese Y; Ohura K
Immunol Lett; 1999 Sep; 69(3):321-7. PubMed ID: 10528796
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
Kawahara S; Kamisaka K; Tada A; Nakada H; Mishima Y; Yoshimoto S; Matsuyama T; Kibata M; Nagare J
Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726
[TBL] [Abstract][Full Text] [Related]
4. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
[TBL] [Abstract][Full Text] [Related]
5. [Studies on effects of new quinolones on superoxide production--with special reference to NADPH oxidase].
Umeki S; Soejima R
Kansenshogaku Zasshi; 1993 Oct; 67(10):998-1004. PubMed ID: 8254220
[TBL] [Abstract][Full Text] [Related]
6. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
Zhao YL; Cai SH; Wang L; Kitaichi K; Tatsumi Y; Nadai M; Yoshizumi H; Takagi K; Takagi K; Hasegawa T
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):167-72. PubMed ID: 11906478
[TBL] [Abstract][Full Text] [Related]
8. Differentiation by in vitro treatment of lidocaine-epinephrine and prilocaine-felypressine in neutrophils.
Azuma Y; Wang PL; Shinohara M; Ohura K
Immunol Lett; 2001 Jul; 77(3):151-8. PubMed ID: 11410247
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
[TBL] [Abstract][Full Text] [Related]
10. Influence of lomefloxacin on phagocytosis and killing activity of macrophages and neutrophils.
Mato R; Corrales I; Prieto J
J Antimicrob Chemother; 1992 Oct; 30(4):558-9. PubMed ID: 1337071
[No Abstract] [Full Text] [Related]
11. Comparison of inhibitory effects of local anesthetics on immune functions of neutrophils.
Azuma Y; Shinohara M; Wang PL; Suese Y; Yasuda H; Ohura K
Int J Immunopharmacol; 2000 Oct; 22(10):789-96. PubMed ID: 10963851
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions.
Azuma Y; Shinohara M; Wang PL; Ohura K
Int Immunopharmacol; 2001 Nov; 1(12):2101-8. PubMed ID: 11710539
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
Ishii Y; Ohno A; Yamaguchi K
Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
Araake M; Hara T; Watabe H; Nishino T
Jpn J Antibiot; 2002 Dec; 55(6):778-90. PubMed ID: 12621732
[TBL] [Abstract][Full Text] [Related]
15. Photohaptenic properties of fluoroquinolones.
Tokura Y; Nishijima T; Yagi H; Furukawa F; Takigawa M
Photochem Photobiol; 1996 Nov; 64(5):838-44. PubMed ID: 8931383
[TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison of cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts.
Omori N; Kobayashi H; Tsutsui T
J Periodontal Res; 1999 Aug; 34(6):290-5. PubMed ID: 10633883
[TBL] [Abstract][Full Text] [Related]
17. Ofloxacin and fleroxacin enhance superoxide production in human polymorphonuclear leukocytes by increasing phosphorylation in the signal transduction pathway.
Matsumoto T; Nagafuji T; Takahashi K; Kubo S; Sakumoto M; Mizunoe Y; Kumazawa J
Int J Antimicrob Agents; 1995 Dec; 6(2):85-9. PubMed ID: 18611690
[TBL] [Abstract][Full Text] [Related]
18. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
Yamashiro Y; Nunome M; Takahata M; Yasuda T
Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277
[TBL] [Abstract][Full Text] [Related]
19. [Antimycobacterial activities of a new quinolone, sparfloxacin].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
[TBL] [Abstract][Full Text] [Related]
20. [Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae].
Maekawa M; Fukuda Y; Sugiura Y; Kamiyama T; Futakuchi N; Takahata M; Mitsuyama J
Jpn J Antibiot; 2003 Feb; 56(1):27-35. PubMed ID: 12723396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
